2,849
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

, , , , , , , , & show all
Pages 1484-1494 | Received 25 Mar 2018, Accepted 14 May 2018, Published online: 19 Jun 2018